H
Hideki Kishikawa
Researcher at Kumamoto University
Publications - 43
Citations - 5091
Hideki Kishikawa is an academic researcher from Kumamoto University. The author has contributed to research in topics: Insulin & Diabetes mellitus. The author has an hindex of 23, co-authored 42 publications receiving 4943 citations.
Papers
More filters
Journal ArticleDOI
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Yasuo Ohkubo,Hideki Kishikawa,Eiichi Araki,Takao Miyata,S. Isami,S. Motoyoshi,Yujiro Kojima,Naohiko Furuyoshi,Motoaki Shichiri +8 more
TL;DR: In conclusion, intensive glycemic control by multiple insulin injection therapy can delay the onset and the progression of diabetic retinopathy, nephropathy and neuropathy in Japanese patients with NIDDM.
Journal Article
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
TL;DR: Intensive glycemic control can delay the onset and progression of the early stages of diabetic microvascular complications in Japanese patients with type 2 diabetes.
Journal ArticleDOI
Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes
Takeshi Nishikawa,Takayuki Sasahara,Shinsuke Kiritoshi,Kazuhiro Sonoda,Takahumi Senokuchi,Tomoko Matsuo,Daisuke Kukidome,Nakayasu Wake,Takeshi Matsumura,Nobuhiro Miyamura,Michiharu Sakakida,Hideki Kishikawa,Eiichi Araki +12 more
TL;DR: Hyperglycemia independently increases 8-OHdG in patients with type 2 diabetes, and this biomarker is a useful biomarker of not only microvascular but also macrovascular complications in Patients withType 2 diabetes.
Journal ArticleDOI
Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: Bradykinin may improve insulin resistance in dogs and humans
M. Uehara,Hideki Kishikawa,S. Isami,K. Kisanuki,Yasuo Ohkubo,Nobuhiro Miyamura,Takao Miyata,Tomohiko Yano,Motoaki Shichiri +8 more
TL;DR: It is concluded that ACE inhibitors with a sulphydryl group have more potent action on the improvement in insulin sensitivity than those without a sulphytol group.
Journal ArticleDOI
Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.
Nakayasu Wake,Akinori Hisashige,Takafumi Katayama,Hideki Kishikawa,Yasuo Ohkubo,Masakazu Sakai,Eiichi Araki,Motoaki Shichiri +7 more
TL;DR: Economic evaluation of a randomized controlled trial on the prevention of diabetes complications in Japan shows that MIT is more beneficial than CIT in both cost and effectiveness, and is recommended for the treatment of type 2 diabetic patients who require insulin therapy as early as possible.